We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fusion Antibodies Plc | LSE:FAB | London | Ordinary Share | GB00BDQZGK16 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.32% | 3.75 | 3.70 | 3.80 | 3.80 | 3.75 | 3.80 | 474,407 | 11:29:57 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.9M | -2.6M | -0.0272 | -1.38 | 3.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
18/9/2020 11:20 | Im actually godsmacked this has such huge potential its unreal | roger148 | |
18/9/2020 11:19 | Tidy It's better than the testing shares. I missed the point they could provide antigens for tests until they mentioned it. My interest is the coat antibodies to neutralise covid which the CEO goes on about in interviews. The CEO is not good at PR. Doc did try to arise the profile but few paid attention. BUT if you look at the underlying business it;'s growing anyway and looking very good, making Covid imo a free bet. But for months no one had paid attention, they have completely missed it. Just 26 mill shares most of which are held by large holders. I estimate 7 mill or so shares for PIs to fight over. Some will think Bio big fund raises for trails, NO FAB are a service provider who took the wise decision to develop covid options 'for sale' themselves. It looks like it was good idea, as they have done this over 200 times before on viruses, the Covid plan was always likely to be a success. | superg1 | |
18/9/2020 11:15 | good post - | tomboyb | |
18/9/2020 11:10 | Roger Nah they raised £3 mill specifically for Covid research. Typically they are a service provider on demand from major pharmas who pay them to engineer antibodies. In the case of Covid they decided to raise money produce the antibodies test it then offer it to pharmas. They are not a big spend company they do not fund drugs trials. It's a very interesting company in the antibody sector who could in theory end up with a finger in neutralising meds for Covid. As explained in posts the whole problem with Covid and viruses, is the body takes up to 2 weeks to develop antibodies. This way patients get a shot in the arm of covid killing antibodies that the body accepts. That's the plan, big pharma will do the testing and trials when they sign up. Such sign ups seem inevitable after that news. Most big names already use Fusion as a service provider | superg1 | |
18/9/2020 11:08 | Good luck to holders one that eluded me I sold out at a pound hoping to get back in before news. Made mistake here but hope it goes on to continue to rocket for you all | fund1 | |
18/9/2020 11:07 | Guess I shouldn’t have sold these for a quid. Back now at 169p lol Should always back my hometown firms | volsung | |
18/9/2020 11:07 | Only 37m cap. Looking at x10 imo compare to AVCT NCYT SNG caps now from this level | tidy 2 | |
18/9/2020 11:05 | 2 quid plus by the look of it - | tomboyb | |
18/9/2020 11:01 | I actually agree for once Cnt knock mcap is very low and news is out as the pandemic is coming back | roger148 | |
18/9/2020 10:57 | This is impressive news for a now 37m cap company with plenty of dosh in the bank and supplying all the big pharmas. | tidy 2 | |
18/9/2020 10:57 | Good read https://spongeshare. | maverick247 | |
18/9/2020 10:56 | Ok seen it Hold my hands up | roger148 | |
18/9/2020 10:55 | Until you check out their balance sheet. | tidy 2 | |
18/9/2020 10:48 | Would say a placing is on route | roger148 | |
18/9/2020 10:45 | 1/10th the cap of other covid stocks. They are not supplying 8 of the top 10 pharmas unlike FAB now is. | tidy 2 | |
18/9/2020 10:36 | Getting a bit hot under the collar - | tomboyb | |
18/9/2020 10:33 | Compare cap here to the recent star covid stocks AVCT NCYT SNG All over £300m cap from FABs low level cap of £32m | tidy 2 | |
18/9/2020 10:27 | hTTps://www.fusionan | tidy 2 | |
18/9/2020 10:27 | Acuere Was that the general antibody type news re progress. I though Fab would see interest due to that but some sold. It forces the point that the market is pretty much oblivious to FAB and its tech. No dob that will change in the coming days and weeks as the usual crew catch on. Some had flirted around it like Doc but the 9.30 news will have caught many out. The underlying business looks interesting before Covid featured. In theory a long way to go for the share price in the coming years on the underlying business but Covid will accelerate that. In theory big pharmas will sign up as they will want a finger in all the pies. | superg1 | |
18/9/2020 10:26 | Surely strong buys to come? | allstars001 | |
18/9/2020 10:25 | acuere18 Sep '20 - 10:14 - 174 of 175 0 1 0 No time to check but is this related to the Eli Lilly announcement this week? no idea - if it is then it could be big big - will take a look - | tomboyb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions